This grant, offered by the Public Health Research Department, is designed to support crucial research on the epidemiology, prevention, and control of influenza and other respiratory viruses, including SARS-CoV-2, in India. The primary purpose is to estimate the incidence of these viruses among working-age adults and priority populations, thereby strengthening the evidence for influenza vaccine policy. This initiative also seeks to identify key risk factors contributing to the disease burden and develop effective strategies for reduction. A significant goal is to uncover potential barriers to influenza and/or SARS-CoV-2 vaccination within priority groups, aiming to inform comprehensive public health interventions.
Opportunity ID: 338613
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-22-001 |
| Funding Opportunity Title: | Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 08, 2022 |
| Last Updated Date: | May 04, 2022 |
| Original Closing Date for Applications: | May 04, 2022 Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date. |
| Current Closing Date for Applications: | May 09, 2022 Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date. |
| Archive Date: | May 29, 2022 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $1,500,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All-India Institute for Medical Sciences (AIIMS, New Delhi) |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The purpose of this notice of funding opportunity (NOFO) is to support research to estimate the incidence of influenza and other respiratory viruses (such as SARS-CoV-2) among working-age adults and other priority populations in India to strengthen the evidence base and to help inform influenza vaccine policy in India. An additional goal is to identify risk factors that contribute to the influenza and/or SARS-CoV-2 burden in India to identify effective strategies to reduce disease burden. The overarching goal is to identify potential barriers to influenza and/or SARS-CoV-2 vaccination in the priority populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson Mosley
FZP0@cdc.gov Email:FZP0@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of this modification is to correct the due date reflected on the synopsis. The due date is 05/09/2022 and is correctly listed throughout the NOFO document. | May 04, 2022 | |
| Mar 08, 2022 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-22-001 |
| Funding Opportunity Title: | Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 08, 2022 |
| Last Updated Date: | May 04, 2022 |
| Original Closing Date for Applications: | May 04, 2022 Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date. |
| Current Closing Date for Applications: | May 09, 2022 Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date. |
| Archive Date: | May 29, 2022 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $1,500,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All-India Institute for Medical Sciences (AIIMS, New Delhi) |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The purpose of this notice of funding opportunity (NOFO) is to support research to estimate the incidence of influenza and other respiratory viruses (such as SARS-CoV-2) among working-age adults and other priority populations in India to strengthen the evidence base and to help inform influenza vaccine policy in India. An additional goal is to identify risk factors that contribute to the influenza and/or SARS-CoV-2 burden in India to identify effective strategies to reduce disease burden. The overarching goal is to identify potential barriers to influenza and/or SARS-CoV-2 vaccination in the priority populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson Mosley
FZP0@cdc.gov Email:FZP0@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-22-001 |
| Funding Opportunity Title: | Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 08, 2022 |
| Last Updated Date: | Mar 08, 2022 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 04, 2022 Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date. |
| Archive Date: | May 29, 2022 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $1,500,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | All-India Institute for Medical Sciences (AIIMS, New Delhi) |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to support research to estimate the incidence of influenza and other respiratory viruses (such as SARS-CoV-2) among working-age adults and other priority populations in India to strengthen the evidence base and to help inform influenza vaccine policy in India. An additional goal is to identify risk factors that contribute to the influenza and/or SARS-CoV-2 burden in India to identify effective strategies to reduce disease burden. The overarching goal is to identify potential barriers to influenza and/or SARS-CoV-2 vaccination in the priority populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson Mosley
FZP0@cdc.gov Email:FZP0@cdc.gov |
Related Documents
Folder 338613 Full Announcement-Full Announcement -> Foa_Content_of_RFA-IP-22-001.pdf
Packages
| Agency Contact Information: | Jocelyn Patterson Mosley FZP0@cdc.gov Email: FZP0@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.083 | RFA-IP-22-001 | Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India | PKG00272496 | Mar 08, 2022 | May 09, 2022 | View |
Package 1
Mandatory forms
338613 RR_SF424_5_0-5.0.pdf
338613 PHS398_CoverPageSupplement_5_0-5.0.pdf
338613 RR_OtherProjectInfo_1_4-1.4.pdf
338613 PHS398_ResearchPlan_4_0-4.0.pdf
338613 PerformanceSite_4_0-4.0.pdf
338613 RR_KeyPersonExpanded_4_0-4.0.pdf
338613 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
338613 RR_Budget_3_0-3.0.pdf
Optional forms
338613 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
